The University of Pennsylvania’s Basser Center for BRCA at the Abramson Cancer Center today announced a $55 million gift from Penn alumni Mindy and Jon Gray to establish the Basser Cancer Interception Institute, creating a new weapon to target hereditary cancers at their earliest stages.
The institute will aim to dramatically disrupt the timeline of cancer treatment, “intercepting” disease when the very first abnormal BRCA1/2 cells develop – or even stopping cancer from developing at all – rather than reducing cancer risk through surgery or treating cancer once it has grown enough to become visible through imaging and testing. The Basser team will pioneer efforts ranging from drugs and immune-based approaches to intercept BRCA-related cancers to new methods of detecting cancer cells with biomarkers and artificial intelligence. Read more.
